Paracetamol price shock looms as Vizag chemists warn 40 percent cost surge risk

Raw material costs tied to West Asia are spiking hard

A war-linked pharma cost shock is now rippling into India’s healthcare market. Vizag chemists say paracetamol and other essential generics may see hikes of 30–40% as manufacturers face surging raw material prices, especially from West Asia. Current supplies are said to be stable, but future revisions could raise retail bills. The government is working to curb volatility and maintain availability.